AU757294B2 - Use of antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection - Google Patents

Use of antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection Download PDF

Info

Publication number
AU757294B2
AU757294B2 AU18844/99A AU1884499A AU757294B2 AU 757294 B2 AU757294 B2 AU 757294B2 AU 18844/99 A AU18844/99 A AU 18844/99A AU 1884499 A AU1884499 A AU 1884499A AU 757294 B2 AU757294 B2 AU 757294B2
Authority
AU
Australia
Prior art keywords
taurolidine
use according
patient
taurultam
faecalis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU18844/99A
Other languages
English (en)
Other versions
AU1884499A (en
Inventor
Rolf Pfirrmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Publication of AU1884499A publication Critical patent/AU1884499A/en
Application granted granted Critical
Publication of AU757294B2 publication Critical patent/AU757294B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AU18844/99A 1998-01-08 1999-01-06 Use of antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection Ceased AU757294B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/004,063 US5972933A (en) 1998-01-08 1998-01-08 Method of treating microbial infections
US09/004063 1998-01-08
PCT/GB1999/000028 WO1999034805A1 (en) 1998-01-08 1999-01-06 Use of antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection

Publications (2)

Publication Number Publication Date
AU1884499A AU1884499A (en) 1999-07-26
AU757294B2 true AU757294B2 (en) 2003-02-13

Family

ID=21708954

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18844/99A Ceased AU757294B2 (en) 1998-01-08 1999-01-06 Use of antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection

Country Status (8)

Country Link
US (1) US5972933A (cg-RX-API-DMAC7.html)
EP (1) EP1044006B1 (cg-RX-API-DMAC7.html)
JP (2) JP2002500189A (cg-RX-API-DMAC7.html)
AU (1) AU757294B2 (cg-RX-API-DMAC7.html)
CA (1) CA2317748C (cg-RX-API-DMAC7.html)
DE (1) DE69934294T2 (cg-RX-API-DMAC7.html)
ES (1) ES2274614T3 (cg-RX-API-DMAC7.html)
WO (1) WO1999034805A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117868A (en) * 1998-09-16 2000-09-12 Ed. Geistlich Sohne Ag Fur Chemische Industrie Treatment of gastrointestinal ulcers or gastritis caused by microbial infection
CA2393159C (en) 1999-12-06 2010-04-20 Paul Calabresi Methods of treating tumors
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
US20020004502A1 (en) * 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
WO2003028642A2 (en) 2001-10-01 2003-04-10 Rhode Island Hospital, A Lifespan Partner Methods of inhibiting metastases
US7240441B2 (en) * 2004-02-12 2007-07-10 Mccoy Ted Excavator thumb for use with excavator equipment
ES2377206T3 (es) 2006-01-06 2012-03-23 Ed Geistlich Sohne Ag Fur Chemische Industrie Composiciones irradiadas y tratamiento de cánceres con radiación en combinación con taurolidina y/o taurultam
US20080008734A1 (en) * 2006-07-05 2008-01-10 Perrault James J Reduction of skin irritation caused by biomedical electrodes
US8548034B2 (en) * 2010-02-08 2013-10-01 Maxlinear, Inc. Methods and apparatus for intelligent power reduction in communications systems
WO2011151722A2 (en) * 2010-06-01 2011-12-08 Geistlich Pharma Ag Methods and compositions for oral pharmaceutical therapy
US20130296223A1 (en) * 2012-03-30 2013-11-07 Sciclone Pharmaceuticals, Inc. Use of thymosin alpha for the treatment of sepsis
WO2014089226A1 (en) 2012-12-04 2014-06-12 The Board Of Trustees Of The University Of Illinois Antibacterial compounds targeting isoprenoid biosynthesis
CA3000868C (en) * 2015-10-07 2025-02-04 Cormedix Inc. SKIN PENETRATION FORMULATION BASED ON TAUROLIDINE
WO2018129061A1 (en) * 2017-01-05 2018-07-12 Cormedix Inc. Antimicrobial delivery system for the prevention and treatment of infections in the colon

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
GB1557163A (en) * 1975-06-24 1979-12-05 Geistlich Soehne Ag Dental care preparations
US4107305A (en) * 1975-08-04 1978-08-15 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Treatment of endotoxaemia
US4002889A (en) * 1975-12-08 1977-01-11 Servo Corporation Of America Self-cleaning label for automatic object identification system
US4337251A (en) * 1979-05-09 1982-06-29 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of avoiding and removing adhesions
CA1190855A (en) * 1980-09-03 1985-07-23 Rolf W. Pfirrmann Treatment of osteitis
GB8328111D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
GB8328073D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
GB8328074D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compositions
DE3506288A1 (de) * 1984-09-06 1986-03-13 Johannes 7900 Ulm Reinmüller Vorrichtung zum einlegen in wunden und wundhoehlen
GB8424518D0 (en) * 1984-09-28 1984-11-07 Geistlich Sohne Af Fur Chemisc Chemical compounds
GB8514055D0 (en) * 1985-06-04 1985-07-10 Geistlich Soehne Ag Chemical substance
DE3533612A1 (de) * 1985-09-20 1987-04-02 Johannes Reinmueller Neuartige verwendung von taurolin
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
GB8813033D0 (en) * 1988-06-02 1988-07-06 Geistlich Soehne Ag Chemical compound
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
GB8827986D0 (en) * 1988-11-30 1989-01-05 Geistlich Soehne Ag Chemical product
ZA909847B (en) * 1989-12-13 1992-08-26 Lilly Co Eli Glycopeptide derivatives
GB9005856D0 (en) * 1990-03-15 1990-05-09 Geistlich Soehne Ag Compositions
US5187082A (en) * 1990-08-16 1993-02-16 Eli Lilly And Company Process for producing A83850 antibiotics
JP3334879B2 (ja) * 1991-04-15 2002-10-15 アンビー インコーポレイテッド 抗胃障害製剤組成物
DE69104608T2 (de) * 1991-07-04 1995-02-16 Weissenfluh Hawe Neos Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis.
GB9216155D0 (en) * 1992-07-30 1992-09-09 Geistlich Soehne Ag Treatment of dentoalveolar infections
US5650320A (en) * 1994-04-20 1997-07-22 University Of Alabama At Birmingham Research Foundation Lanthionine antibiotic compositions and methods
GB9600426D0 (en) * 1996-01-10 1996-03-13 Ed Geistlich Sohne A G Compositions
ES2163000T3 (es) * 1996-01-16 2002-01-16 Advanced Polymer Systems Inc Suministro topico de farmacos al tracto gastrointestinal inferior.

Also Published As

Publication number Publication date
JP2002500189A (ja) 2002-01-08
ES2274614T3 (es) 2007-05-16
EP1044006B1 (en) 2006-12-06
JP2010174032A (ja) 2010-08-12
JP5469511B2 (ja) 2014-04-16
EP1044006A1 (en) 2000-10-18
US5972933A (en) 1999-10-26
WO1999034805A1 (en) 1999-07-15
DE69934294D1 (de) 2007-01-18
CA2317748C (en) 2008-07-08
AU1884499A (en) 1999-07-26
CA2317748A1 (en) 1999-07-15
DE69934294T2 (de) 2007-07-05

Similar Documents

Publication Publication Date Title
JP5469511B2 (ja) 微生物の院内感染症の治療用医薬の製造におけるタウロリジンまたはタウラルタムのような抗微生物薬剤の使用
RU2607660C2 (ru) Композиция, содержащая антибиотик и диспергирующее средство или антиадгезивный агент
ES2339003T3 (es) Rifalazil para tratar infecciones por clostridium difficile.
JP5410748B2 (ja) 抗菌剤およびカルベオール、チモール、オイゲノール、ボルネオールならびにカルバクロールから選択される活性成分を含んでなる医薬組成物
CA3035686C (en) New use of triazolo(4,5-d)pyrimidine derivatives for prevention and treatment of bacterial infection
US20180256592A1 (en) Antibacterial compositions
JP2002500189A5 (cg-RX-API-DMAC7.html)
WO2004017925A2 (en) Methods and reagents for preventing bacteremias
CN102143751A (zh) 利福拉齐治疗结肠疾病的用途
KR101157486B1 (ko) 경구용 항미생물성 제약학적 조성물
EA016803B1 (ru) Лечение инфекционных заболеваний
JP2008534224A (ja) デバイス内細菌感染処置用の改良された方法及び装置
US6858589B2 (en) Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria
Slack et al. The microbiological and pharmacokinetic profile of an antibacterial agent useful for the single-dose therapy of urinary tract infection
US20200093826A1 (en) New use of triazolo(4,5 d)pyrimidine derivatives for prevention and treatment of bacterial infection
Vazqueza et al. Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits
Graninger et al. Intravenous ofloxacin in severe infections
CN101912402B (zh) 一种头孢西酮钠和克拉维酸钾的组合物及其配比
HK40053249A (en) Use of rifamycin-quinolizidone coupling molecule and pharmaceutically acceptable salt thereof
BR122024018415A2 (pt) Usos de derivados de triazolo(4,5-d) pirimidina, e método para neutralização de bactérias ou prevenção do crescimento bacteriano na formação de biofilme
AU2012205123A1 (en) Methods and reagents for treating infections of clostridium difficile and diseases associate therewith

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired